GB Patent

GB9823871D0 — 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents

Assigned to Pfizer Italia SRL · Expires 1998-12-23 · 27y expired

What this patent protects

Patent listed against ponatinib-hydrochloride.

Drugs covered by this patent

ponatinib-hydrochloride (PONATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: GB9823871D0
Jurisdiction: GB
Classification: —
Expires: 1998-12-23
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Italia SRL
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.